A Tasisulam and Midazolam Drug Interaction Study in Cancer Patients

NCT01209832 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

11

Enrollment

INDUSTRY

Sponsor class

Stopped Terminated based on safety results from another trial

Conditions

Advanced Cancer

Interventions

DRUG: Tasisulam
DRUG: Midazolam

Sponsor

Eli Lilly and Company